1. Home
  2. JFIN vs ZVRA Comparison

JFIN vs ZVRA Comparison

Compare JFIN & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JFIN
  • ZVRA
  • Stock Information
  • Founded
  • JFIN 2011
  • ZVRA 2006
  • Country
  • JFIN China
  • ZVRA United States
  • Employees
  • JFIN N/A
  • ZVRA N/A
  • Industry
  • JFIN Finance: Consumer Services
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • JFIN Finance
  • ZVRA Health Care
  • Exchange
  • JFIN Nasdaq
  • ZVRA Nasdaq
  • Market Cap
  • JFIN 472.3M
  • ZVRA 467.6M
  • IPO Year
  • JFIN 2019
  • ZVRA 2015
  • Fundamental
  • Price
  • JFIN $9.39
  • ZVRA $9.08
  • Analyst Decision
  • JFIN
  • ZVRA Strong Buy
  • Analyst Count
  • JFIN 0
  • ZVRA 7
  • Target Price
  • JFIN N/A
  • ZVRA $21.71
  • AVG Volume (30 Days)
  • JFIN 78.6K
  • ZVRA 1.7M
  • Earning Date
  • JFIN 11-20-2025
  • ZVRA 11-05-2025
  • Dividend Yield
  • JFIN 8.56%
  • ZVRA N/A
  • EPS Growth
  • JFIN 33.85
  • ZVRA N/A
  • EPS
  • JFIN 4.21
  • ZVRA 0.54
  • Revenue
  • JFIN $908,895,698.00
  • ZVRA $84,388,000.00
  • Revenue This Year
  • JFIN N/A
  • ZVRA $336.43
  • Revenue Next Year
  • JFIN N/A
  • ZVRA $54.26
  • P/E Ratio
  • JFIN $2.14
  • ZVRA $16.93
  • Revenue Growth
  • JFIN 8.19
  • ZVRA 244.60
  • 52 Week Low
  • JFIN $5.18
  • ZVRA $6.19
  • 52 Week High
  • JFIN $19.23
  • ZVRA $13.16
  • Technical
  • Relative Strength Index (RSI)
  • JFIN 42.09
  • ZVRA 39.42
  • Support Level
  • JFIN $8.65
  • ZVRA $9.67
  • Resistance Level
  • JFIN $9.65
  • ZVRA $10.56
  • Average True Range (ATR)
  • JFIN 0.50
  • ZVRA 0.58
  • MACD
  • JFIN 0.05
  • ZVRA -0.24
  • Stochastic Oscillator
  • JFIN 43.35
  • ZVRA 21.87

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: